Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software
- PMID: 28070841
- DOI: 10.1007/s11547-016-0720-8
Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software
Abstract
Purpose: Dynamic susceptibility contrast MRI (DSC) and dynamic contrast-enhanced MRI (DCE) are useful tools in the diagnosis and follow-up of brain gliomas; nevertheless, both techniques leave the open issue of data reproducibility. We evaluated the reproducibility of data obtained using two different commercial software for perfusion maps calculation and analysis, as one of the potential sources of variability can be the software itself.
Methods: DSC and DCE analyses from 20 patients with gliomas were tested for both the intrasoftware (as intraobserver and interobserver reproducibility) and the intersoftware reproducibility, as well as the impact of different postprocessing choices [vascular input function (VIF) selection and deconvolution algorithms] on the quantification of perfusion biomarkers plasma volume (Vp), volume transfer constant (K trans) and rCBV. Data reproducibility was evaluated with the intraclass correlation coefficient (ICC) and Bland-Altman analysis.
Results: For all the biomarkers, the intra- and interobserver reproducibility resulted in almost perfect agreement in each software, whereas for the intersoftware reproducibility the value ranged from 0.311 to 0.577, suggesting fair to moderate agreement; Bland-Altman analysis showed high dispersion of data, thus confirming these findings. Comparisons of different VIF estimation methods for DCE biomarkers resulted in ICC of 0.636 for K trans and 0.662 for Vp; comparison of two deconvolution algorithms in DSC resulted in an ICC of 0.999.
Conclusions: The use of single software ensures very good intraobserver and interobservers reproducibility. Caution should be taken when comparing data obtained using different software or different postprocessing within the same software, as reproducibility is not guaranteed anymore.
Keywords: Dynamic contrast-enhanced MRI (DCE); Dynamic susceptibility contrast MRI (DSC); Gliomas; Perfusion weighted MRI; Reproducibility of findings; Vascular input function (VIF).
Similar articles
-
Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.Eur J Radiol. 2016 Jun;85(6):1147-56. doi: 10.1016/j.ejrad.2016.03.020. Epub 2016 Mar 22. Eur J Radiol. 2016. PMID: 27161065
-
Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.Radiology. 2018 Jun;287(3):933-943. doi: 10.1148/radiol.2017170362. Epub 2018 Jan 22. Radiology. 2018. PMID: 29361245
-
Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.J Magn Reson Imaging. 2018 Apr;47(4):1099-1111. doi: 10.1002/jmri.25835. Epub 2017 Aug 28. J Magn Reson Imaging. 2018. PMID: 28845594
-
The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing Gliomas.Radiology. 2024 Dec;313(3):e232555. doi: 10.1148/radiol.232555. Radiology. 2024. PMID: 39656118 Review.
-
Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice.Magn Reson Imaging Clin N Am. 2016 Nov;24(4):649-670. doi: 10.1016/j.mric.2016.06.005. Epub 2016 Sep 14. Magn Reson Imaging Clin N Am. 2016. PMID: 27742108 Review.
Cited by
-
Advanced MRI Protocols to Discriminate Glioma From Treatment Effects: State of the Art and Future Directions.Front Radiol. 2022 Apr 15;2:809373. doi: 10.3389/fradi.2022.809373. eCollection 2022. Front Radiol. 2022. PMID: 37492687 Free PMC article. Review.
-
Reproducibility of dynamic contrast enhanced MRI derived transfer coefficient Ktrans in lung cancer.PLoS One. 2022 Mar 8;17(3):e0265056. doi: 10.1371/journal.pone.0265056. eCollection 2022. PLoS One. 2022. PMID: 35259199 Free PMC article.
-
Standardized acquisition and post-processing of dynamic susceptibility contrast perfusion in patients with brain tumors, cerebrovascular disease and dementia: comparability of post-processing software.Br J Radiol. 2020 Jan;93(1105):20190543. doi: 10.1259/bjr.20190543. Epub 2019 Oct 24. Br J Radiol. 2020. PMID: 31617743 Free PMC article.
-
A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors.Neuroradiology. 2023 Mar;65(3):559-568. doi: 10.1007/s00234-022-03072-y. Epub 2022 Oct 27. Neuroradiology. 2023. PMID: 36301349 Free PMC article.
-
Inter-observer reproducibility of quantitative dynamic susceptibility contrast and diffusion MRI parameters in histogram analysis of gliomas.Acta Radiol. 2020 Jan;61(1):76-84. doi: 10.1177/0284185119852729. Epub 2019 Jun 3. Acta Radiol. 2020. PMID: 31159557 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical